[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Unicon Optical Co. Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":31,"leadSponsor":33,"locationsCount":36},"100617714",false,"NCT07322211","A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses","Inclusion Criteria:\n\n1. Adult with an age ≥ 18;\n2. Be a currently adapted soft contact lens wearer who successful wear of soft contact lenses in both eyes for a minimum of 5 days per week and 6 hours per day within 3 months prior to study screening (by verbal confirmation);\n3. Participant must be stop wearing any contact lenses more than 7 days prior to screening;\n4. Able to wear contact lenses within a range of power from -2.00D to -6.00D (0.25 D steps) in both eyes;\n5. Astigmatism of 1.25D or less in both eyes;\n6. Be correctable to a visual acuity of 1.0 decimal (0.0 logMAR) or better in each eye;\n7. Participant must be able to be successfully fit with study lenses;\n8. The participant must appear able and willing to adhere to the instructions set forth in this clinical protocol;\n9. The participant must read and sign the Informed Consent Form.\n\nExclusion Criteria:\n\n1. Women who are currently pregnant;\n2. Women who are lactating or planning a pregnancy at the time of enrollment (by verbal confirmation at the screening visit);\n3. Any use of systemic or ocular medications (e.g., non-steroidal anti-inflammatory eye drops, ophthalmic steroids) within 30 days prior to study enrollment for which contact lens wear could be contraindicated, as determined by the investigator;\n4. Any current or history ocular or systemic disease which may interfere with contact lens wear, as determined by the investigator;\n5. Any current or previous orthokeratology treatment within 90 days prior to study enrollment, or planned for orthokeratology treatment during the study;\n6. Any previous history of ocular and\u002For refractive surgery (e.g., radial keratotomy, PRK, LASIK, etc.) or planned for ocular and\u002For refractive surgery during the study;\n7. Current or history of herpetic keratitis in either eye;\n8. Current or history of intolerance, hypersensitivity or allergy to silicone hydrogel soft contact lenses or any component of the study products;\n9. Current clinical finding of entropion, ectropion, chalazia, recurrent styes, glaucoma, pathologically dry eye (defined as Schirmer test \\\u003C 5 mm\u002F5 min), recurrent corneal erosions, aphakia, or moderate or above corneal distortion;\n10. Employee of Department of Ophthalmology and clinic (e.g., Investigator, Coordinator, Technician);\n11. Participation in any interventional clinical trial within 30 days prior to study enrollment;\n12. Any biomicroscopy findings at screening that are Grade 3 or higher and\u002For corneal neovascularization that is Grade 2 or higher and\u002For presence of corneal infiltrates;\n13. Any history of a contact lens-related corneal inflammatory or infectious event within 12 months prior to study enrollment that may contraindicate contact lens wear;\n14. Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator;\n15. Participants are considered ineligible for the study as judged by the investigator.","ALL","18 Days",{"count":17,"type":18},35,"ESTIMATED","INTERVENTIONAL",[21],"NA","13 weeks, open-label, daily disposable contact lens dispensing study.",[24],"Refractive Ametropia","RECRUITING","2026-01-20",{"date":28,"type":29},"2026-01-22","ACTUAL",{"date":26,"type":29},{"date":32,"type":18},"2026-10-31",{"name":34,"class":35},"Unicon Optical Co. Ltd.","INDUSTRY",2,""]